Cyclooxygenases (COXs) are enzymes that catalyze the rate-limiting step in the conversion of arachidonic acid to prostaglandins. Cyclooxygenases are also known as Prostaglandins H Synthase.
1. The document discusses cyclooxygenase (COX) enzymes and their role in mediating prostaglandin formation and inflammation.
2. Nonsteroidal anti-inflammatory drugs (NSAIDs) work by inhibiting COX enzymes, specifically COX-1 and COX-2, which inhibits prostaglandin production and subsequent inflammation.
3. NSAIDs are commonly used to treat conditions involving pain and inflammation like arthritis, headaches, and menstrual cramps. Their main side effects involve potential risks to the cardiovascular and gastrointestinal systems.
COX enzymes are responsible for formation of prostaglandins that mediate inflammation and pain. There are three types of COX enzymes - COX-1, COX-2, and COX-3. COX-2 produces prostaglandins mainly involved in the inflammatory response. COX-2 inhibitors selectively inhibit COX-2 to reduce inflammation and pain with fewer gastrointestinal side effects than non-selective NSAIDs that inhibit both COX-1 and COX-2. Celecoxib is currently the only COX-2 inhibitor available in the United States to treat conditions like arthritis. Potential side effects of COX-2 inhibitors include stomach ulcers, heart attacks, and strokes.
The document summarizes several COX inhibitors including both selective and non-selective inhibitors. It describes the synthesis, chemical structure, mechanism of action, absorption, distribution, metabolism, excretion, and side effects of various COX inhibitors including Celecoxib, Rofecoxib, Valdecoxib, Parecoxib, and Aspirin. The document also provides background information on COX-1 and COX-2 enzymes and their role in the inflammatory response.
COX inhibitors have been known to cause platelet inhibition by inhibiting thromboxane A2 production. Aspirin causes irreversible inhibition of COX, and therefore, the duration of platelet inhibition lasts until 7 to 10 days after drug discontinuation.
A type of drug that is used to treat inflammation and pain, and is being studied in the prevention and treatment of cancer. COX inhibitors belong to the family of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). Also called cyclooxygenase inhibitor.
COX-2 inhibitors are a type of nonsteroidal anti-inflammatory drug (NSAID) that directly targets cyclooxygenase-2, COX-2, an enzyme responsible for inflammation and pain. Targeting selectivity for COX-2 reduces the risk of peptic ulceration and is the main feature of celecoxib, rofecoxib, and other members of this drug class.Coxibs are NSAIDs that are highly selective for the COX2 enzyme. Because the COX2 enzyme mediates prostaglandin production responsible for inflammation and pain, coxibs are analgesic and antiinflammatory, but they lack the side effects related to inhibiting the COX1 enzyme (e.g., bleeding and gastrointestinal irritation).
Selective cox 2 inhibitors design by siddharthSiddharth Jain
The document discusses selective COX-2 inhibitors, which are a type of NSAID that selectively binds to the COX-2 enzyme responsible for inflammation and pain. It provides background on the COX-1 and COX-2 enzymes and reasons for developing selective COX-2 inhibitors to avoid the side effects of non-selective NSAIDs like ulceration and bleeding. The key structural differences between COX-1 and COX-2 that allow for selective inhibitor design are described. Examples of important selective COX-2 inhibitors developed include celecoxib and parecoxib.
A Powerpoint presentation on the basics of Eicosanoids which includes Prostaglandins, Leukotrienes (LTs) ad Platelete Activating Factors (PAF) suitable for Undergraduate level Medical students.
1. The document discusses cyclooxygenase (COX) enzymes and their role in mediating prostaglandin formation and inflammation.
2. Nonsteroidal anti-inflammatory drugs (NSAIDs) work by inhibiting COX enzymes, specifically COX-1 and COX-2, which inhibits prostaglandin production and subsequent inflammation.
3. NSAIDs are commonly used to treat conditions involving pain and inflammation like arthritis, headaches, and menstrual cramps. Their main side effects involve potential risks to the cardiovascular and gastrointestinal systems.
COX enzymes are responsible for formation of prostaglandins that mediate inflammation and pain. There are three types of COX enzymes - COX-1, COX-2, and COX-3. COX-2 produces prostaglandins mainly involved in the inflammatory response. COX-2 inhibitors selectively inhibit COX-2 to reduce inflammation and pain with fewer gastrointestinal side effects than non-selective NSAIDs that inhibit both COX-1 and COX-2. Celecoxib is currently the only COX-2 inhibitor available in the United States to treat conditions like arthritis. Potential side effects of COX-2 inhibitors include stomach ulcers, heart attacks, and strokes.
The document summarizes several COX inhibitors including both selective and non-selective inhibitors. It describes the synthesis, chemical structure, mechanism of action, absorption, distribution, metabolism, excretion, and side effects of various COX inhibitors including Celecoxib, Rofecoxib, Valdecoxib, Parecoxib, and Aspirin. The document also provides background information on COX-1 and COX-2 enzymes and their role in the inflammatory response.
COX inhibitors have been known to cause platelet inhibition by inhibiting thromboxane A2 production. Aspirin causes irreversible inhibition of COX, and therefore, the duration of platelet inhibition lasts until 7 to 10 days after drug discontinuation.
A type of drug that is used to treat inflammation and pain, and is being studied in the prevention and treatment of cancer. COX inhibitors belong to the family of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). Also called cyclooxygenase inhibitor.
COX-2 inhibitors are a type of nonsteroidal anti-inflammatory drug (NSAID) that directly targets cyclooxygenase-2, COX-2, an enzyme responsible for inflammation and pain. Targeting selectivity for COX-2 reduces the risk of peptic ulceration and is the main feature of celecoxib, rofecoxib, and other members of this drug class.Coxibs are NSAIDs that are highly selective for the COX2 enzyme. Because the COX2 enzyme mediates prostaglandin production responsible for inflammation and pain, coxibs are analgesic and antiinflammatory, but they lack the side effects related to inhibiting the COX1 enzyme (e.g., bleeding and gastrointestinal irritation).
Selective cox 2 inhibitors design by siddharthSiddharth Jain
The document discusses selective COX-2 inhibitors, which are a type of NSAID that selectively binds to the COX-2 enzyme responsible for inflammation and pain. It provides background on the COX-1 and COX-2 enzymes and reasons for developing selective COX-2 inhibitors to avoid the side effects of non-selective NSAIDs like ulceration and bleeding. The key structural differences between COX-1 and COX-2 that allow for selective inhibitor design are described. Examples of important selective COX-2 inhibitors developed include celecoxib and parecoxib.
A Powerpoint presentation on the basics of Eicosanoids which includes Prostaglandins, Leukotrienes (LTs) ad Platelete Activating Factors (PAF) suitable for Undergraduate level Medical students.
Prostaglandin, leukotriene, and thromboxaneGeeta Jaiswal
Eicosanoids are signaling molecules derived from polyunsaturated fatty acids like arachidonic acid. They are involved in complex control over inflammation, immunity, and the central nervous system. Eicosanoids are synthesized through the enzymatic oxidation of fatty acids by cyclooxygenase and lipoxygenase enzymes. They have short half-lives and act locally through autocrine and paracrine signaling. Examples of important eicosanoids include prostaglandins, thromboxanes, and leukotrienes.
This document discusses prostaglandins and leukotrienes, local hormones derived from arachidonic acid that have many functions in the body. It describes their biosynthesis pathways through cyclooxygenase and lipoxygenase enzymes, and the actions of specific prostaglandins and leukotrienes in processes like inflammation, smooth muscle tone, blood coagulation, and reproduction. The document also outlines their roles in conditions like peptic ulcers, glaucoma, erectile dysfunction, and pulmonary issues. Prostaglandin preparations are used for therapeutic abortion, cervical ripening, postpartum hemorrhage, and various ulcer and eye conditions. Side effects can include vomiting, diarrhea, and abdominal cramps.
COX inhibitors like NSAIDs work as nonopioid analgesics and anti-inflammatory drugs. They function by inhibiting the COX enzymes and thereby decreasing the production of prostaglandins and other inflammatory mediators derived from arachidonic acid. This leads to their analgesic, antipyretic, and anti-inflammatory effects but also side effects involving the gastrointestinal tract and kidney function. Aspirin is a prototypical NSAID that was first isolated from willow bark and introduced in 1899, demonstrating the clinical usefulness of this class of drugs.
Non-steroidal anti-inflammatory drugs (NSAIDs) work by inhibiting the enzyme cyclooxygenase (COX) and subsequent prostaglandin synthesis. They are classified based on selectivity for COX-1 vs COX-2. Common side effects include gastric irritation, while selective COX-2 inhibitors were developed to reduce this but increase cardiovascular risk. NSAIDs are used for analgesic, antipyretic and anti-inflammatory effects in conditions like arthritis, but choice depends on safety profile and potency needed.
The document discusses prostaglandins, including their classification, biosynthesis, physiological effects, and inhibitors. It summarizes a 1971 study that discovered the mechanism of action of aspirin and other NSAIDs. The study found that incubating guinea pig lung tissue with arachidonic acid leads to increased production of prostaglandins PGE2 and PGF2α over time. Aspirin, indomethacin, and sodium salicylate were shown to inhibit this prostaglandin production in a dose-dependent manner. This established that aspirin-like drugs work by inhibiting the enzyme that synthesizes prostaglandins from arachidonic acid.
Statins are a class of drugs that lower cholesterol by inhibiting the enzyme HMG-CoA reductase. They work by competing with HMG-CoA for binding to the active site of the enzyme, which reduces cholesterol production in the liver. Common statins include atorvastatin, fluvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin, and simvastatin. Statins are prescribed to reduce cardiovascular disease risk, both as a primary prevention for those at high risk due to factors like age, cholesterol levels, blood pressure, or smoking, and as a secondary prevention for those who have already developed cardiovascular disease.
Seretonin (5HT) and Its Antagonists PharmacologyPranatiChavan
Serotonin is a chemical that has a wide variety of functions in the human body. It is sometimes called the happy chemical, because it contributes to wellbeing and happiness.
The scientific name for serotonin is 5-hydroxytryptamine, or 5-HT. It is mainly found in the brain, bowels, and blood platelets.
Serotonin is used to transmit messages between nerve cells, it is thought to be active in constricting smooth muscles, and it contributes to wellbeing and happiness, among other things. As the precursor for melatonin, it helps regulate the body’s sleep-wake cycles and the internal clock.
It is thought to play a role in appetite, the emotions, and motor, cognitive, and autonomic functions. However, it is not known exactly if serotonin affects these directly, or if it has an overall role in co-ordinating the nervous system.
This document presents information on parasympathomimetics, which are drugs that mimic the effects of parasympathetic nervous system stimulation. It discusses how parasympathomimetics can directly activate cholinergic receptors through agonists like acetylcholine, muscarine, and pilocarpine. It also describes how anticholinesterase drugs inhibit the acetylcholinesterase enzyme, increasing the availability of acetylcholine at cholinergic synapses. Specific parasympathomimetic drugs discussed include bethanechol, carbachol, pilocarpine, and echothiophate. The document provides details on the mechanisms of action and therapeutic uses of these cholinergic drugs.
This document summarizes the concepts of agonists and antagonists in receptor activation and inhibition. It defines agonists as ligands that enhance receptor activity and antagonists as those that oppose agonist action and block receptor activation. The document compares the properties and types of agonists, including full, partial, and inverse agonists, and antagonists, including competitive, non-competitive, and irreversible antagonists. It discusses how agonists and antagonists regulate signaling pathways through their effects on receptor activation and inhibition.
(Eicosanoids) Prostaglandins, leucotrienes, and platelet activating factorsPranatiChavan
Prostaglandins (PGs) and Leukotrienes (LTs) are biologically active derivatives of 20 carbon atom polyunsaturated essential fatty acids that are released from cell membrane phospholipids. They are the major lipid derived autacoids.
NSAIDs are a group of drugs that reduce pain, fever, and inflammation by inhibiting the COX enzymes that produce prostaglandins. COX enzymes exist in two forms, COX-1 and COX-2. NSAIDs work by blocking both forms of COX, though some are more selective for COX-2. This inhibition of COX reduces prostaglandin production and subsequent pain/fever/inflammation. However, it can also reduce platelet count and increase risk of stomach ulcers. NSAIDs are classified into several categories based on their chemical structure and mechanisms of action. The structure of individual NSAIDs influences their biological activity and side effect profiles.
Any of a group of potent hormone like substances that are produced in various mammalian tissues, are derived from arachidonic acid, and mediate a wide range of physiological functions, such as control of blood pressure, contraction of uterine, smooth muscle, and modulation of inflammation.
Adrenergic agonists and antagonists act on adrenergic receptors. Agonists like epinephrine and norepinephrine directly stimulate receptors, whereas antagonists like prazosin competitively block receptor activation. These drugs have widespread effects throughout the body due to the sympathetic nervous system's role in functions like heart rate, blood pressure, bronchodilation and uterine contraction. Care must be taken with certain drugs that can cause severe side effects like hypotension or bronchospasm.
NSAIDs are a group of drugs that relieve pain, fever, and inflammation by inhibiting prostaglandin synthesis. They can be classified based on their action on COX enzymes or their chemical structure. Their mechanism of action involves blocking COX pathways to prevent the formation of prostaglandins. Common adverse effects include gastric irritation and impaired healing. NSAIDs should be used cautiously in patients with conditions like peptic ulcer or impaired kidney function.
Prostaglandins are locally acting lipid compounds derived from arachidonic acid. They have diverse hormone-like effects and are synthesized in almost every tissue. The main classes are prostaglandin D2, E2, F2α, I2, and thromboxane A2. They regulate processes like uterine contraction, bronchodilation, inflammation, and gastric acid secretion. Prostaglandins are rapidly degraded and have short half-lives. Nonsteroidal anti-inflammatory drugs inhibit their synthesis. Clinically, prostaglandins are used to induce labor, treat ulcers, control bleeding, and manage glaucoma and erectile dysfunction. Side effects include diarrhea, abdominal pain, and darkening of
Autacoids - pharmacological actions and drugs related to them. SIVASWAROOP YARASI
Autacoids or "autocoids" are biological factors which act like local hormones, have a brief duration, and act near the site of synthesis. The word autacoids comes from the Greek "autos" (self) and "acos" (relief, i.e. drug).
This document discusses prostaglandins, which are locally acting hormone-like lipid mediators derived from arachidonic acid. Prostaglandins have diverse roles in processes like inflammation, fever regulation, and reproduction. They act by binding G protein-coupled receptors on target cells. Nonsteroidal anti-inflammatory drugs inhibit prostaglandin production by blocking the enzyme prostaglandin-H synthase. Aspirin irreversibly inhibits this enzyme through acetylation, reducing thromboxane formation in platelets and thus having an anti-clotting effect.
Leukotrienes are inflammatory mediators produced from the oxidation of arachidonic acid by leukocytes, mast cells, and macrophages. They are produced in response to immunological and non-immunological stimuli. There are two main types of leukotrienes - leukotriene B4, which is a chemoattractant for neutrophils, and cysteinyl leukotrienes (LTC4, LTD4, LTE4), which are produced by mast cells and eosinophils and cause bronchoconstriction. Leukotrienes exert their effects through G-protein coupled receptors and trigger intracellular signaling cascades involving phospholipase C and increases in intracellular calcium. They
NSAIDs are commonly used analgesic, antipyretic and anti-inflammatory drugs. They work by inhibiting cyclooxygenase (COX) enzymes, decreasing synthesis of prostaglandins. There are two main COX isoforms, COX-1 and COX-2. NSAIDs can be nonselective inhibitors of both isoforms or selective inhibitors of COX-2. The main pharmacological effects of NSAIDs are analgesia, antipyresis and reduction of inflammation by decreasing prostaglandin levels. However, they also carry risks of adverse gastrointestinal, renal and platelet effects due to inhibition of the constitutive COX-1 isoform.
This document summarizes anti-inflammatory drugs. It discusses the inflammatory process and mediators like histamine, prostaglandins, leukotrienes and thromboxane A2. It describes the three phases of inflammation and signs like redness, heat, swelling and pain. Two major classes of anti-inflammatory drugs are discussed: steroidal anti-inflammatory drugs (SAIDs) like cortisone and hydrocortisone, and non-steroidal anti-inflammatory drugs (NSAIDs) like aspirin, ibuprofen and naproxen. The mechanisms, common uses and potential side effects of various NSAIDs are outlined.
Prostaglandin, leukotriene, and thromboxaneGeeta Jaiswal
Eicosanoids are signaling molecules derived from polyunsaturated fatty acids like arachidonic acid. They are involved in complex control over inflammation, immunity, and the central nervous system. Eicosanoids are synthesized through the enzymatic oxidation of fatty acids by cyclooxygenase and lipoxygenase enzymes. They have short half-lives and act locally through autocrine and paracrine signaling. Examples of important eicosanoids include prostaglandins, thromboxanes, and leukotrienes.
This document discusses prostaglandins and leukotrienes, local hormones derived from arachidonic acid that have many functions in the body. It describes their biosynthesis pathways through cyclooxygenase and lipoxygenase enzymes, and the actions of specific prostaglandins and leukotrienes in processes like inflammation, smooth muscle tone, blood coagulation, and reproduction. The document also outlines their roles in conditions like peptic ulcers, glaucoma, erectile dysfunction, and pulmonary issues. Prostaglandin preparations are used for therapeutic abortion, cervical ripening, postpartum hemorrhage, and various ulcer and eye conditions. Side effects can include vomiting, diarrhea, and abdominal cramps.
COX inhibitors like NSAIDs work as nonopioid analgesics and anti-inflammatory drugs. They function by inhibiting the COX enzymes and thereby decreasing the production of prostaglandins and other inflammatory mediators derived from arachidonic acid. This leads to their analgesic, antipyretic, and anti-inflammatory effects but also side effects involving the gastrointestinal tract and kidney function. Aspirin is a prototypical NSAID that was first isolated from willow bark and introduced in 1899, demonstrating the clinical usefulness of this class of drugs.
Non-steroidal anti-inflammatory drugs (NSAIDs) work by inhibiting the enzyme cyclooxygenase (COX) and subsequent prostaglandin synthesis. They are classified based on selectivity for COX-1 vs COX-2. Common side effects include gastric irritation, while selective COX-2 inhibitors were developed to reduce this but increase cardiovascular risk. NSAIDs are used for analgesic, antipyretic and anti-inflammatory effects in conditions like arthritis, but choice depends on safety profile and potency needed.
The document discusses prostaglandins, including their classification, biosynthesis, physiological effects, and inhibitors. It summarizes a 1971 study that discovered the mechanism of action of aspirin and other NSAIDs. The study found that incubating guinea pig lung tissue with arachidonic acid leads to increased production of prostaglandins PGE2 and PGF2α over time. Aspirin, indomethacin, and sodium salicylate were shown to inhibit this prostaglandin production in a dose-dependent manner. This established that aspirin-like drugs work by inhibiting the enzyme that synthesizes prostaglandins from arachidonic acid.
Statins are a class of drugs that lower cholesterol by inhibiting the enzyme HMG-CoA reductase. They work by competing with HMG-CoA for binding to the active site of the enzyme, which reduces cholesterol production in the liver. Common statins include atorvastatin, fluvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin, and simvastatin. Statins are prescribed to reduce cardiovascular disease risk, both as a primary prevention for those at high risk due to factors like age, cholesterol levels, blood pressure, or smoking, and as a secondary prevention for those who have already developed cardiovascular disease.
Seretonin (5HT) and Its Antagonists PharmacologyPranatiChavan
Serotonin is a chemical that has a wide variety of functions in the human body. It is sometimes called the happy chemical, because it contributes to wellbeing and happiness.
The scientific name for serotonin is 5-hydroxytryptamine, or 5-HT. It is mainly found in the brain, bowels, and blood platelets.
Serotonin is used to transmit messages between nerve cells, it is thought to be active in constricting smooth muscles, and it contributes to wellbeing and happiness, among other things. As the precursor for melatonin, it helps regulate the body’s sleep-wake cycles and the internal clock.
It is thought to play a role in appetite, the emotions, and motor, cognitive, and autonomic functions. However, it is not known exactly if serotonin affects these directly, or if it has an overall role in co-ordinating the nervous system.
This document presents information on parasympathomimetics, which are drugs that mimic the effects of parasympathetic nervous system stimulation. It discusses how parasympathomimetics can directly activate cholinergic receptors through agonists like acetylcholine, muscarine, and pilocarpine. It also describes how anticholinesterase drugs inhibit the acetylcholinesterase enzyme, increasing the availability of acetylcholine at cholinergic synapses. Specific parasympathomimetic drugs discussed include bethanechol, carbachol, pilocarpine, and echothiophate. The document provides details on the mechanisms of action and therapeutic uses of these cholinergic drugs.
This document summarizes the concepts of agonists and antagonists in receptor activation and inhibition. It defines agonists as ligands that enhance receptor activity and antagonists as those that oppose agonist action and block receptor activation. The document compares the properties and types of agonists, including full, partial, and inverse agonists, and antagonists, including competitive, non-competitive, and irreversible antagonists. It discusses how agonists and antagonists regulate signaling pathways through their effects on receptor activation and inhibition.
(Eicosanoids) Prostaglandins, leucotrienes, and platelet activating factorsPranatiChavan
Prostaglandins (PGs) and Leukotrienes (LTs) are biologically active derivatives of 20 carbon atom polyunsaturated essential fatty acids that are released from cell membrane phospholipids. They are the major lipid derived autacoids.
NSAIDs are a group of drugs that reduce pain, fever, and inflammation by inhibiting the COX enzymes that produce prostaglandins. COX enzymes exist in two forms, COX-1 and COX-2. NSAIDs work by blocking both forms of COX, though some are more selective for COX-2. This inhibition of COX reduces prostaglandin production and subsequent pain/fever/inflammation. However, it can also reduce platelet count and increase risk of stomach ulcers. NSAIDs are classified into several categories based on their chemical structure and mechanisms of action. The structure of individual NSAIDs influences their biological activity and side effect profiles.
Any of a group of potent hormone like substances that are produced in various mammalian tissues, are derived from arachidonic acid, and mediate a wide range of physiological functions, such as control of blood pressure, contraction of uterine, smooth muscle, and modulation of inflammation.
Adrenergic agonists and antagonists act on adrenergic receptors. Agonists like epinephrine and norepinephrine directly stimulate receptors, whereas antagonists like prazosin competitively block receptor activation. These drugs have widespread effects throughout the body due to the sympathetic nervous system's role in functions like heart rate, blood pressure, bronchodilation and uterine contraction. Care must be taken with certain drugs that can cause severe side effects like hypotension or bronchospasm.
NSAIDs are a group of drugs that relieve pain, fever, and inflammation by inhibiting prostaglandin synthesis. They can be classified based on their action on COX enzymes or their chemical structure. Their mechanism of action involves blocking COX pathways to prevent the formation of prostaglandins. Common adverse effects include gastric irritation and impaired healing. NSAIDs should be used cautiously in patients with conditions like peptic ulcer or impaired kidney function.
Prostaglandins are locally acting lipid compounds derived from arachidonic acid. They have diverse hormone-like effects and are synthesized in almost every tissue. The main classes are prostaglandin D2, E2, F2α, I2, and thromboxane A2. They regulate processes like uterine contraction, bronchodilation, inflammation, and gastric acid secretion. Prostaglandins are rapidly degraded and have short half-lives. Nonsteroidal anti-inflammatory drugs inhibit their synthesis. Clinically, prostaglandins are used to induce labor, treat ulcers, control bleeding, and manage glaucoma and erectile dysfunction. Side effects include diarrhea, abdominal pain, and darkening of
Autacoids - pharmacological actions and drugs related to them. SIVASWAROOP YARASI
Autacoids or "autocoids" are biological factors which act like local hormones, have a brief duration, and act near the site of synthesis. The word autacoids comes from the Greek "autos" (self) and "acos" (relief, i.e. drug).
This document discusses prostaglandins, which are locally acting hormone-like lipid mediators derived from arachidonic acid. Prostaglandins have diverse roles in processes like inflammation, fever regulation, and reproduction. They act by binding G protein-coupled receptors on target cells. Nonsteroidal anti-inflammatory drugs inhibit prostaglandin production by blocking the enzyme prostaglandin-H synthase. Aspirin irreversibly inhibits this enzyme through acetylation, reducing thromboxane formation in platelets and thus having an anti-clotting effect.
Leukotrienes are inflammatory mediators produced from the oxidation of arachidonic acid by leukocytes, mast cells, and macrophages. They are produced in response to immunological and non-immunological stimuli. There are two main types of leukotrienes - leukotriene B4, which is a chemoattractant for neutrophils, and cysteinyl leukotrienes (LTC4, LTD4, LTE4), which are produced by mast cells and eosinophils and cause bronchoconstriction. Leukotrienes exert their effects through G-protein coupled receptors and trigger intracellular signaling cascades involving phospholipase C and increases in intracellular calcium. They
NSAIDs are commonly used analgesic, antipyretic and anti-inflammatory drugs. They work by inhibiting cyclooxygenase (COX) enzymes, decreasing synthesis of prostaglandins. There are two main COX isoforms, COX-1 and COX-2. NSAIDs can be nonselective inhibitors of both isoforms or selective inhibitors of COX-2. The main pharmacological effects of NSAIDs are analgesia, antipyresis and reduction of inflammation by decreasing prostaglandin levels. However, they also carry risks of adverse gastrointestinal, renal and platelet effects due to inhibition of the constitutive COX-1 isoform.
This document summarizes anti-inflammatory drugs. It discusses the inflammatory process and mediators like histamine, prostaglandins, leukotrienes and thromboxane A2. It describes the three phases of inflammation and signs like redness, heat, swelling and pain. Two major classes of anti-inflammatory drugs are discussed: steroidal anti-inflammatory drugs (SAIDs) like cortisone and hydrocortisone, and non-steroidal anti-inflammatory drugs (NSAIDs) like aspirin, ibuprofen and naproxen. The mechanisms, common uses and potential side effects of various NSAIDs are outlined.
eicosanoids by doctor Mariam namusoke phdKawukiIsah
The document discusses the metabolism and biological properties of eicosanoids. It defines eicosanoids as derivatives of essential fatty acids that act as local hormones. Eicosanoids include prostaglandins, thromboxanes, leukotrienes, lipoxins, and hydroxyeicosatetraenoic acids (HETEs). They are produced in tissues from arachidonic acid through the cyclooxygenase pathway (forming prostaglandins and thromboxanes) or lipoxygenase pathway (forming leukotrienes, lipoxins, and HETEs). Eicosanoids have diverse functions like mediating inflammation, regulating pain and fever, modulating blood pressure, and facilitating platelet aggregation
1. Arachidonic acid is released from cell membranes and metabolized via either the cyclooxygenase pathway or lipoxygenase pathway to produce prostaglandins, thromboxanes, leukotrienes, and lipoxins.
2. These metabolites are involved in various physiological and pathological processes such as inflammation, hemostasis, smooth muscle contraction, and pain sensation.
3. Nonsteroidal anti-inflammatory drugs function by inhibiting cyclooxygenase, thereby blocking prostaglandin production and reducing inflammation.
ROLE OF ANTI-INFLAMMATORY DRUGS IN SURGERYDR AMEER HAMZA
Inflammation is the body's protective response to injury or infection that involves immune cells, blood vessels, and molecular mediators. It causes redness, heat, swelling, and pain. There are three phases: acute, delayed, and chronic. Mediators like prostaglandins and histamine cause vasodilation, increased permeability, and pain. Steroidal anti-inflammatory drugs and non-steroidal anti-inflammatory drugs inhibit inflammation by different mechanisms. NSAIDs inhibit the COX enzyme to prevent prostaglandin production, while steroids inhibit phospholipase A2. Both drug classes can cause side effects with long term use like gastric irritation.
Cyclooxygenase (COX) is an enzyme that catalyzes the formation of prostanoids like thromboxane and prostaglandins from arachidonic acid. It exists in two isoforms, COX-1 and COX-2. COX-1 is constitutively expressed while COX-2 is inducible during inflammation. Nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit COX enzymes to exert their effects. Kinetic studies show that nitric oxide can increase the activity of COX-2 but not COX-1 by enhancing its maximum reaction rate and decreasing its Michaelis constant for oxygen. Understanding the differences between COX-1 and COX-2
This document discusses anti-inflammatory agents known as NSAIDs. It first outlines the features of inflammation and mechanism of action of NSAIDs, which work by inhibiting the cyclooxygenase enzymes COX-1 and COX-2 that produce prostaglandins involved in inflammation. It then classifies NSAIDs into nonselective COX inhibitors including aspirin, paracetamol, phenylbutazone, piroxicam, and meclofenamate. Selective COX-2 inhibitors are also mentioned. The synthesis of mefenamic acid and ibuprofen are briefly outlined.
There are two types of cyclooxygenase (COX) enzymes, COX-1 and COX-2, that produce prostaglandins and promote inflammation. Nonsteroidal anti-inflammatory drugs (NSAIDs) target these enzymes to reduce inflammation. While both COX enzymes produce prostaglandins that cause inflammation, pain, and fever, only COX-1 produces prostaglandins that protect the stomach lining. Some NSAIDs and newer drugs selectively inhibit either COX-1 or COX-2 in order to reduce side effects. NS-398 and FK881 are examples of inhibitors that selectively target COX-2 and COX-1, respectively.
The eicosanoids are oxygenation products of polyunsaturated
long-chain fatty acids. They are ubiquitous in the animal kingdom
and are also found—together with their precursors—in a variety
of plants. They constitute a very large family of compounds that
are highly potent and display an extraordinarily wide spectrum of
biologic activity. Because of their biologic activity, the eicosanoids,
their specific receptor antagonists and enzyme inhibitors, and
their plant and fish oil precursors have great therapeutic potential.
this file is all about eicosanoids including prostaglandins,prostacyclins and leukutriens with its mechanism of formation and inhibitors of LOX and COX pathways
This document discusses the treatment of muscle pain and disorders. It covers the mechanisms and uses of skeletal muscle relaxants, NSAIDs, and local injection therapies like corticosteroids and anesthetics. It compares the mechanisms of action, uses, and side effects of selective and non-selective NSAIDs. The key resources listed provide information on controlling muscle pain using NSAIDs, muscle relaxants, and local therapies for muscle disorders.
This document discusses prostaglandins and nonsteroidal anti-inflammatory drugs (NSAIDs). It explains that prostaglandins are formed from arachidonic acid through the cyclooxygenase (COX) pathway. NSAIDs work by inhibiting the COX enzymes, thereby reducing prostaglandin formation. The document outlines the classes of NSAIDs and their molecular targets. It also discusses the differences between COX-1 and COX-2, and the development of selective COX-2 inhibitors to reduce side effects of traditional NSAIDs.
International Journal of Pharmaceutical Science Invention (IJPSI) is an international journal intended for professionals and researchers in all fields of Pahrmaceutical Science. IJPSI publishes research articles and reviews within the whole field Pharmacy and Pharmaceutical Science, new teaching methods, assessment, validation and the impact of new technologies and it will continue to provide information on the latest trends and developments in this ever-expanding subject. The publications of papers are selected through double peer reviewed to ensure originality, relevance, and readability. The articles published in our journal can be accessed online.
This document discusses anti-inflammatory drugs and NSAIDs. It begins by describing inflammation, its phases and signs. It then discusses the mediators of inflammation like histamine, bradykinin, prostaglandins and leukotrienes. NSAIDs work by inhibiting cyclooxygenase enzymes, decreasing prostaglandin synthesis and thus the inflammatory response. Aspirin irreversibly inhibits cyclooxygenase while other NSAIDs are reversible inhibitors. NSAIDs provide analgesic, antipyretic and anti-inflammatory effects through these mechanisms. Side effects can include gastrointestinal irritation.
There are two cyclooxygenase enzymes, COX-1 and COX-2. COX-1 is constitutively expressed in the gastrointestinal tract, while COX-2 predominates at sites of inflammation. Selective COX-2 inhibitors were developed to inhibit prostaglandin synthesis at sites of inflammation without damaging the gastrointestinal tract like traditional NSAIDs. Studies have shown that the COX-2 inhibitors rofecoxib and celecoxib significantly reduce ulcers and gastrointestinal bleeding compared to NSAIDs. However, aspirin use may reduce the benefits of COX-2 inhibitors, and naproxen may protect against vascular disease more than COX-2 inhibitors or placebo.
The eicosanoids are a family of lipophilic hormones derived from arachidonic acid. They act locally and are involved in inflammation by regulating processes like vasodilation, vascular permeability, pain, and leukocyte recruitment. Many eicosanoids, like prostaglandins, thromboxanes, and leukotrienes, are rapidly metabolized near their site of synthesis. Their production is stimulated by extracellular signals and they act through modulating downstream signaling pathways. Many drugs target the production or activity of specific eicosanoids to treat inflammatory conditions.
This document summarizes inflammation and anti-inflammatory drugs. It describes the phases of inflammation, signs of inflammation, and mediators of the inflammatory response such as histamine, bradykinin, prostaglandins, and leukotrienes. It then discusses nonsteroidal anti-inflammatory drugs (NSAIDs) and their mechanisms of action by inhibiting cyclooxygenase enzymes and decreasing prostaglandin synthesis. Common NSAIDs are described including their pharmacological properties, mechanisms of action, therapeutic uses, and potential adverse effects such as gastrointestinal issues and bleeding risks.
1) Arachidonic acid is released from cell membranes and converted by COX enzymes into prostaglandins, which mediate pain and inflammation.
2) NSAIDs like aspirin work by inhibiting COX enzymes, reducing prostaglandin production and thus pain and inflammation, but can increase risk of ulcers.
3) COX-2 selective inhibitors like etoricoxib mainly inhibit COX-2, providing anti-inflammatory effects with fewer gastrointestinal side effects than non-selective NSAIDs.
This document summarizes anti-inflammatory drugs and NSAIDs. It describes the inflammatory process and key mediators like prostaglandins. NSAIDs work by inhibiting cyclooxygenase enzymes, decreasing prostaglandin production and thus reducing inflammation, pain, and fever. Common NSAIDs like aspirin do this through reversible or irreversible inhibition of COX-1 and COX-2. The document outlines their mechanisms of action, therapeutic uses, and potential adverse effects like gastrointestinal irritation and bleeding.
Eicosanoids are signalling molecules derived from polyunsaturated fatty acids like arachidonic acid. They include prostaglandins, thromboxanes, leukotrienes, and lipoxins. Eicosanoids function as local hormones and have diverse physiological effects, such as modulating inflammation and immune responses. They are synthesized from cell membranes when needed and act locally before being rapidly degraded.
How to Make a Field Mandatory in Odoo 17Celine George
In Odoo, making a field required can be done through both Python code and XML views. When you set the required attribute to True in Python code, it makes the field required across all views where it's used. Conversely, when you set the required attribute in XML views, it makes the field required only in the context of that particular view.
This presentation was provided by Steph Pollock of The American Psychological Association’s Journals Program, and Damita Snow, of The American Society of Civil Engineers (ASCE), for the initial session of NISO's 2024 Training Series "DEIA in the Scholarly Landscape." Session One: 'Setting Expectations: a DEIA Primer,' was held June 6, 2024.
This slide is special for master students (MIBS & MIFB) in UUM. Also useful for readers who are interested in the topic of contemporary Islamic banking.
বাংলাদেশের অর্থনৈতিক সমীক্ষা ২০২৪ [Bangladesh Economic Review 2024 Bangla.pdf] কম্পিউটার , ট্যাব ও স্মার্ট ফোন ভার্সন সহ সম্পূর্ণ বাংলা ই-বুক বা pdf বই " সুচিপত্র ...বুকমার্ক মেনু 🔖 ও হাইপার লিংক মেনু 📝👆 যুক্ত ..
আমাদের সবার জন্য খুব খুব গুরুত্বপূর্ণ একটি বই ..বিসিএস, ব্যাংক, ইউনিভার্সিটি ভর্তি ও যে কোন প্রতিযোগিতা মূলক পরীক্ষার জন্য এর খুব ইম্পরট্যান্ট একটি বিষয় ...তাছাড়া বাংলাদেশের সাম্প্রতিক যে কোন ডাটা বা তথ্য এই বইতে পাবেন ...
তাই একজন নাগরিক হিসাবে এই তথ্য গুলো আপনার জানা প্রয়োজন ...।
বিসিএস ও ব্যাংক এর লিখিত পরীক্ষা ...+এছাড়া মাধ্যমিক ও উচ্চমাধ্যমিকের স্টুডেন্টদের জন্য অনেক কাজে আসবে ...
Main Java[All of the Base Concepts}.docxadhitya5119
This is part 1 of my Java Learning Journey. This Contains Custom methods, classes, constructors, packages, multithreading , try- catch block, finally block and more.
A workshop hosted by the South African Journal of Science aimed at postgraduate students and early career researchers with little or no experience in writing and publishing journal articles.
2. Cyclooxygenases (COX)
• Cyclooxygenases (COXs) are enzymes that catalyze the rate-limiting
step in the conversion of arachidonic acid to prostaglandins
• Cyclooxygenases are also known as Prostaglandins H Synthase.
• This enzyme converts arachidonic acid, a fatty acid in cell membranes,
into prostaglandins, modified fatty acids attached to a ring of five
carbons.
• Prostaglandins (PGs) are hormone-like bioactive substances involved
in many physiological and pathological processes
4. Types of COX enzyme
Conversation of Arachidonic acid to Prostaglandins is mediated by
Cyclo-oxygenases which are of two types COX 1 and COX 2.
1.COX 1 : Constitutive , activated by physiologic stimuli.
2.COX 2 : Inducible by Pro-inflammatory stimuli It has two active site
COX-1 and COX-2 are very similar in structure (60- 65% of the sequence
is conserved), however they are expressed in different parts of the
body.
5.
6. Cyclooxygenase site, where arachidonic acid is converted into the
hydroperoxy endoperoxide ProstaGlandin G2 (PGG2).
• Heme with peroxidase activity, responsible for the conversion of PGG2
to PGH2.
• Which is then converted into prostanoids (PGD2, PGF2α PGE2,
thromboxane A2, PGI2)by specific isomerase enzymes
Active site of COX
8. COX 2
• COX 2 is an Inducible enzyme that acts to speed up the production of
certain chemical messengers, called prostaglandins that play a key role
in promoting inflammation.
• COX-2 is located in macrophages, leukocytes and fibroblasts.
Structural Domains of COX 2
• N-terminal epidermal growth factor (EGF)
• A Membrane Binding Domain (MBD)
• A large C-terminal globular catalytic domain
10. Prostaglandins produced by COX 2
• The prostaglandins produced by COX 2 are Used for signaling pain and
inflammation.
• It Produces prostaglandins for inflammatory response.
• Production is stimulated by inflammatory cytokines and growth
factors.
11. MECHANISM OF ACTION OF
PROSTAGLANDINS VIA cAMP PATHWAY
Prostaglandin I2 (PGI2,
prostacyclin).
It causes relaxation of
vascular smooth muscle
and inhibits platelet
aggregation.
13. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
• NSAIDs produce anti-inflammatory, anti-pyretic and analgesic effects.
• Finding ways of reducing pain and inflammation are key roles of
NSAIDs
• The mechanism of these drugs is due to their binding ability to the
active sites of COX , preventing the catalysis of Arachidonic acid to
prostaglandins
14. NSAIDs
• NSAIDs binds irreversibly to COX enzymes and inhibit their action i.e
the conversion of Arachidonic acid to the prostaglandins.
• NSAIDs acetylates the actives site of COX enzyme which causes
inhibition.
• Some examples of NSAIDs are:
• Aspirin
• ibuprofen
• Piroxicam etc
15. Side effects of NSAIDs
Aspirin and other similar NSAIDs lead to excessive production of
stomach acid as well as ulceration and gastrointestinal bleeding.
NSAIDs can prolong the bleeding time
NSAIDs can increase blood pressure.
These all side effects are due to the inhibition of COX1’s house
keeping role.
17. Categories of NSAIDs
NSAIDS can be divided into the following
categories:
Non-selective COX inhibitor (Naproxen,
ibuprofen and piroxicam).
Selective COX-2 inhibitors (meloxicam,
Celecoxib and diclofenac).
18. COX 2 Inhibitors (COXIBs)
• As COX 2 has role in inflammation and pyrexia. So it is desirous to inhibit COX-2.
There are different types of drugs that are used to inhibit COX-2 enzyme including
Celecoxib.
• COX-2 inhibitors (COXIBs) are a special category of NSAIDs that target only COX-2
enzymes.
• COX-2 inhibitors also don’t offer the same kind of protection against heart
disease.
20. Celecoxib
• Since aspirin is nonselective to both
COX1 and COX2 it shows duel effects
• Celecoxib shows selectivity to COX2 thus
inhibiting only the inflammatory
prostaglandins and not the COX1 house
keeping prostaglandins
22. The mechanisms by which COX-2 contributes
to cancer Activation of
carcinogens
Prostaglandins
and Apoptosis
Prostaglandins
and increased
invasiveness
Prostaglandins
and
Angiogenesis
Prostaglandins
and cell
proliferation
Prostaglandins
and immune
response